https://doi.org/10.4081/mem.2018.540
Clinical and ethical use of induced pluripotent stem cells / Uso clinico ed etico delle cellule pluripotenti indotte
Submitted: July 30, 2018
Accepted: July 30, 2018
Published: July 30, 2018
Accepted: July 30, 2018
Abstract Views: 965
PDF (Italiano): 7
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Since its discovery, more than a decade ago, induced pluripotent stem cells (iPS) have had a prominent relevance in the environments of biomedical research and, at the same time, their origin has been related to the search for an ethical alternative to use of the stem cells obtained from internal mass of the human embryo. In this article we intend to give an overview of its possible applications in the advancement of biomedicine and its relationship with bioethics. From its possible application to regenerate tissues, after proceeding to their differentiation; testing of drugs for different conditions; or their use in models of diseases, among which the neurological ones stand out. Also, its application in obtaining germ cells and human embryos. The situation of the first clinical trial to regenerate a tissue from the subject's own iPS cells, and the recent allogeneic transplantation in Japan, suggest advances in the clinical translation of these cells. On the other hand, the production of germ cells from iPS cells and the new cells called extended pluripotent stem cells (EPS), obtained by genetic reprogramming through a chemical cocktail, that give rise not only to the tissues of the embryonic layers, but also extra- embryonic, are a new path to making clonation by another route.----------Fin dalla sua scoperta, per oltre un decennio, cellule staminali pluripotenti indotte (iPS) hanno un'importanza notevole nella ricerca biomedica ambienti e, allo stesso tempo, la sua origine è legata alla ricerca di un'alternativa etica all'utilizzo le cellule staminali ottenute dalla massa interna dell'embrione umano. In questo articolo diamo una panoramica delle possibili applicazioni nell'avanzamento biomedicina e la loro relazione bioetica. Dalla sua possibile applicazione di rigenerare il tessuto, quindi procedere alla differenziazione; la sperimentazione di farmaci per diversi disturbi; o il suo uso in modelli di malattie, tra cui spiccano quelle neurologiche. Così come la sua applicazione nell'ottenere cellule germinali e embrioni umani. La situazione del primo studio clinico per rigenerare un tessuto da cellule iPS e proprio trapianto recente del soggetto in Giappone rappresentano passi nella traduzione clinica di queste cellule. Inoltre la produzione di cellule germinali dalle cellule iPS e nuove cellule chiamate cellule staminali pluripotenti estesi (EPS), riprogrammando geneticamente da un cocktail chimico, causando non solo ai tessuti degli strati embrionali, ma extraembrionali anche costituire un nuovo percorso verso la clonazione di un altro itinerario.
How to Cite
Millás-Mur, J. (2018). Clinical and ethical use of induced pluripotent stem cells / Uso clinico ed etico delle cellule pluripotenti indotte. Medicina E Morale, 67(3), 291–305. https://doi.org/10.4081/mem.2018.540
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
An Open Access Publication is one that meets the following two conditions:
- the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
- a complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.